6657 — Energenesis Biomedical Co Balance Sheet
0.000.00%
Last trade - 00:00
- TWD4.20bn
- TWD3.51bn
- TWD7.16m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 643 | 544 | 726 | 485 | 699 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.84 | 1.62 | 1.66 | 1.86 | 2.26 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 654 | 554 | 740 | 503 | 719 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 77.6 | 79.8 | 89 | 82.5 | 77.2 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 814 | 705 | 886 | 631 | 829 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 18.2 | 22.8 | 27.2 | 24.4 | 21.3 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 27.1 | 32.5 | 33.4 | 28.3 | 24.6 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 786 | 673 | 852 | 603 | 804 |
Total Liabilities & Shareholders' Equity | 814 | 705 | 886 | 631 | 829 |
Total Common Shares Outstanding |